Multicentre Italian Trials in Ovarian cancer (MITO) translational group. Development and validation of a microRNA-based signature (MiROvaR) to predict early relapse or progression of epithelial ovarian cancer: a cohort study

Bagnoli M;Canevari S;Califano D;Losito S;Maio MD;Raspagliesi F;Carcangiu ML;Toffoli G;Cecchin E;Sorio R;Canzonieri V;Russo D;Scognamiglio G;Chiappetta G;Baldassarre G;Lorusso D;Scambia G;Zannoni GF;Savarese A;Carosi M;Scollo P;Breda E;Murgia V;Perrone F;Pignata S;De Cecco L;Mezzanzanica D

2016-01-01